nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ALB—metabolic syndrome X	0.526	1	CbGaD
Gefitinib—Vandetanib—FMO3—metabolic syndrome X	0.00564	0.336	CrCbGaD
Gefitinib—CHEK2—adipose tissue—metabolic syndrome X	0.00541	0.0592	CbGeAlD
Gefitinib—Erlotinib—NR1I2—metabolic syndrome X	0.0045	0.268	CrCbGaD
Gefitinib—Appetite absent—Metformin—metabolic syndrome X	0.00425	0.118	CcSEcCtD
Gefitinib—ERBB3—kidney—metabolic syndrome X	0.00367	0.0402	CbGeAlD
Gefitinib—MKNK2—cardiovascular system—metabolic syndrome X	0.00357	0.0391	CbGeAlD
Gefitinib—EGFR—adipose tissue—metabolic syndrome X	0.00357	0.039	CbGeAlD
Gefitinib—MKNK1—cardiovascular system—metabolic syndrome X	0.00353	0.0386	CbGeAlD
Gefitinib—CSNK1E—adipose tissue—metabolic syndrome X	0.00343	0.0375	CbGeAlD
Gefitinib—IRAK4—adipose tissue—metabolic syndrome X	0.00338	0.037	CbGeAlD
Gefitinib—ERBB3—adipose tissue—metabolic syndrome X	0.00331	0.0362	CbGeAlD
Gefitinib—Nail disorder—Metformin—metabolic syndrome X	0.00326	0.0907	CcSEcCtD
Gefitinib—MKNK2—adipose tissue—metabolic syndrome X	0.00315	0.0345	CbGeAlD
Gefitinib—IRAK1—adipose tissue—metabolic syndrome X	0.00315	0.0345	CbGeAlD
Gefitinib—MKNK1—adipose tissue—metabolic syndrome X	0.00311	0.034	CbGeAlD
Gefitinib—STK10—cardiovascular system—metabolic syndrome X	0.0029	0.0318	CbGeAlD
Gefitinib—STK10—kidney—metabolic syndrome X	0.00284	0.0311	CbGeAlD
Gefitinib—MAP2K5—cardiovascular system—metabolic syndrome X	0.00259	0.0284	CbGeAlD
Gefitinib—STK10—adipose tissue—metabolic syndrome X	0.00256	0.028	CbGeAlD
Gefitinib—EGFR—liver—metabolic syndrome X	0.0025	0.0274	CbGeAlD
Gefitinib—CSNK1E—liver—metabolic syndrome X	0.00241	0.0263	CbGeAlD
Gefitinib—IRAK4—liver—metabolic syndrome X	0.00237	0.0259	CbGeAlD
Gefitinib—ERBB3—liver—metabolic syndrome X	0.00232	0.0254	CbGeAlD
Gefitinib—MAP2K5—adipose tissue—metabolic syndrome X	0.00229	0.025	CbGeAlD
Gefitinib—MKNK2—liver—metabolic syndrome X	0.00221	0.0242	CbGeAlD
Gefitinib—IRAK1—liver—metabolic syndrome X	0.00221	0.0242	CbGeAlD
Gefitinib—MKNK1—liver—metabolic syndrome X	0.00218	0.0239	CbGeAlD
Gefitinib—Minaprine—HTR2C—metabolic syndrome X	0.00212	0.127	CrCbGaD
Gefitinib—STK10—liver—metabolic syndrome X	0.0018	0.0196	CbGeAlD
Gefitinib—Cisapride—HTR2C—metabolic syndrome X	0.00168	0.1	CrCbGaD
Gefitinib—MAP2K5—liver—metabolic syndrome X	0.0016	0.0175	CbGeAlD
Gefitinib—Iloperidone—HTR2C—metabolic syndrome X	0.00155	0.0923	CrCbGaD
Gefitinib—Dehydration—Metformin—metabolic syndrome X	0.00143	0.0397	CcSEcCtD
Gefitinib—ABCB1—blood vessel—metabolic syndrome X	0.00139	0.0153	CbGeAlD
Gefitinib—ORM1—liver—metabolic syndrome X	0.0013	0.0142	CbGeAlD
Gefitinib—Pancreatitis—Metformin—metabolic syndrome X	0.0013	0.0362	CcSEcCtD
Gefitinib—Infestation—Metformin—metabolic syndrome X	0.00118	0.0329	CcSEcCtD
Gefitinib—Infestation NOS—Metformin—metabolic syndrome X	0.00118	0.0329	CcSEcCtD
Gefitinib—CYP1A1—kidney—metabolic syndrome X	0.00117	0.0128	CbGeAlD
Gefitinib—CYP2C9—cardiovascular system—metabolic syndrome X	0.00115	0.0126	CbGeAlD
Gefitinib—CYP3A5—kidney—metabolic syndrome X	0.00115	0.0125	CbGeAlD
Gefitinib—ALB—liver—metabolic syndrome X	0.00114	0.0125	CbGeAlD
Gefitinib—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00112	0.0311	CcSEcCtD
Gefitinib—ABCG2—adipose tissue—metabolic syndrome X	0.00111	0.0122	CbGeAlD
Gefitinib—Hepatitis—Metformin—metabolic syndrome X	0.00106	0.0295	CcSEcCtD
Gefitinib—CYP1A1—adipose tissue—metabolic syndrome X	0.00106	0.0116	CbGeAlD
Gefitinib—Oedema peripheral—Metformin—metabolic syndrome X	0.00105	0.0291	CcSEcCtD
Gefitinib—CYP3A5—adipose tissue—metabolic syndrome X	0.00103	0.0113	CbGeAlD
Gefitinib—Eye disorder—Metformin—metabolic syndrome X	0.000992	0.0276	CcSEcCtD
Gefitinib—Cardiac disorder—Metformin—metabolic syndrome X	0.000985	0.0274	CcSEcCtD
Gefitinib—Angiopathy—Metformin—metabolic syndrome X	0.000963	0.0268	CcSEcCtD
Gefitinib—Mediastinal disorder—Metformin—metabolic syndrome X	0.000957	0.0266	CcSEcCtD
Gefitinib—Malnutrition—Metformin—metabolic syndrome X	0.000924	0.0257	CcSEcCtD
Gefitinib—CYP2C19—liver—metabolic syndrome X	0.000919	0.0101	CbGeAlD
Gefitinib—CYP3A4—kidney—metabolic syndrome X	0.00086	0.00941	CbGeAlD
Gefitinib—CYP2D6—kidney—metabolic syndrome X	0.000846	0.00926	CbGeAlD
Gefitinib—Malaise—Metformin—metabolic syndrome X	0.000833	0.0232	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000781	0.0217	CcSEcCtD
Gefitinib—ABCG2—liver—metabolic syndrome X	0.00078	0.00853	CbGeAlD
Gefitinib—Erlotinib—ALB—metabolic syndrome X	0.000777	0.0463	CrCbGaD
Gefitinib—Infection—Metformin—metabolic syndrome X	0.000749	0.0208	CcSEcCtD
Gefitinib—Shock—Metformin—metabolic syndrome X	0.000742	0.0206	CcSEcCtD
Gefitinib—CYP1A1—liver—metabolic syndrome X	0.000741	0.0081	CbGeAlD
Gefitinib—Nervous system disorder—Metformin—metabolic syndrome X	0.00074	0.0206	CcSEcCtD
Gefitinib—Thrombocytopenia—Metformin—metabolic syndrome X	0.000739	0.0205	CcSEcCtD
Gefitinib—Skin disorder—Metformin—metabolic syndrome X	0.000733	0.0204	CcSEcCtD
Gefitinib—CYP3A5—liver—metabolic syndrome X	0.000724	0.00792	CbGeAlD
Gefitinib—Anorexia—Metformin—metabolic syndrome X	0.000719	0.02	CcSEcCtD
Gefitinib—CYP2C9—liver—metabolic syndrome X	0.000713	0.0078	CbGeAlD
Gefitinib—Hypotension—Metformin—metabolic syndrome X	0.000705	0.0196	CcSEcCtD
Gefitinib—Dyspnoea—Metformin—metabolic syndrome X	0.000672	0.0187	CcSEcCtD
Gefitinib—Decreased appetite—Metformin—metabolic syndrome X	0.000656	0.0182	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000651	0.0181	CcSEcCtD
Gefitinib—Fatigue—Metformin—metabolic syndrome X	0.00065	0.0181	CcSEcCtD
Gefitinib—Constipation—Metformin—metabolic syndrome X	0.000645	0.0179	CcSEcCtD
Gefitinib—ABCB1—cardiovascular system—metabolic syndrome X	0.000622	0.00681	CbGeAlD
Gefitinib—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000617	0.0172	CcSEcCtD
Gefitinib—ABCB1—kidney—metabolic syndrome X	0.000609	0.00666	CbGeAlD
Gefitinib—Urticaria—Metformin—metabolic syndrome X	0.000599	0.0167	CcSEcCtD
Gefitinib—Abdominal pain—Metformin—metabolic syndrome X	0.000596	0.0166	CcSEcCtD
Gefitinib—ABCB1—adipose tissue—metabolic syndrome X	0.000549	0.006	CbGeAlD
Gefitinib—CYP3A4—liver—metabolic syndrome X	0.000544	0.00595	CbGeAlD
Gefitinib—Asthenia—Metformin—metabolic syndrome X	0.000541	0.0151	CcSEcCtD
Gefitinib—CYP2D6—liver—metabolic syndrome X	0.000535	0.00585	CbGeAlD
Gefitinib—Pruritus—Metformin—metabolic syndrome X	0.000534	0.0148	CcSEcCtD
Gefitinib—Diarrhoea—Metformin—metabolic syndrome X	0.000516	0.0144	CcSEcCtD
Gefitinib—Vandetanib—ALB—metabolic syndrome X	0.000512	0.0305	CrCbGaD
Gefitinib—Vomiting—Metformin—metabolic syndrome X	0.00048	0.0133	CcSEcCtD
Gefitinib—Rash—Metformin—metabolic syndrome X	0.000476	0.0132	CcSEcCtD
Gefitinib—Dermatitis—Metformin—metabolic syndrome X	0.000475	0.0132	CcSEcCtD
Gefitinib—Nausea—Metformin—metabolic syndrome X	0.000448	0.0125	CcSEcCtD
Gefitinib—ABCB1—liver—metabolic syndrome X	0.000385	0.00421	CbGeAlD
Gefitinib—ABCG2—Metabolism—AGT—metabolic syndrome X	2.44e-05	7.39e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CETP—metabolic syndrome X	2.44e-05	7.39e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—FABP4—metabolic syndrome X	2.43e-05	7.37e-05	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	2.43e-05	7.37e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—metabolic syndrome X	2.42e-05	7.34e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—metabolic syndrome X	2.4e-05	7.28e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—SERPINE1—metabolic syndrome X	2.4e-05	7.27e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NOS3—metabolic syndrome X	2.4e-05	7.27e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	2.4e-05	7.26e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	2.39e-05	7.25e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	2.39e-05	7.25e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—APOE—metabolic syndrome X	2.39e-05	7.25e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GGT1—metabolic syndrome X	2.38e-05	7.22e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GOT1—metabolic syndrome X	2.38e-05	7.22e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—LIPC—metabolic syndrome X	2.38e-05	7.22e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GCK—metabolic syndrome X	2.38e-05	7.22e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	2.38e-05	7.2e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOC3—metabolic syndrome X	2.37e-05	7.17e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—APOA1—metabolic syndrome X	2.36e-05	7.16e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.36e-05	7.16e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GCK—metabolic syndrome X	2.36e-05	7.15e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—LIPC—metabolic syndrome X	2.36e-05	7.15e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOC3—metabolic syndrome X	2.35e-05	7.11e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SCARB1—metabolic syndrome X	2.34e-05	7.08e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.33e-05	7.06e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	2.32e-05	7.04e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	2.31e-05	6.99e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CETP—metabolic syndrome X	2.3e-05	6.96e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS3—metabolic syndrome X	2.29e-05	6.94e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CETP—metabolic syndrome X	2.28e-05	6.9e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.27e-05	6.88e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SREBF1—metabolic syndrome X	2.27e-05	6.87e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GOT2—metabolic syndrome X	2.26e-05	6.85e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	2.26e-05	6.85e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ABCA1—metabolic syndrome X	2.24e-05	6.8e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SLC2A4—metabolic syndrome X	2.24e-05	6.8e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—AKT1—metabolic syndrome X	2.24e-05	6.77e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—metabolic syndrome X	2.22e-05	6.73e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—AKT1—metabolic syndrome X	2.22e-05	6.72e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GOT2—metabolic syndrome X	2.21e-05	6.68e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—HMGCR—metabolic syndrome X	2.21e-05	6.68e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	2.2e-05	6.67e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AGT—metabolic syndrome X	2.19e-05	6.62e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	2.18e-05	6.61e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GGT1—metabolic syndrome X	2.17e-05	6.58e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GOT1—metabolic syndrome X	2.17e-05	6.58e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	2.16e-05	6.55e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LEP—metabolic syndrome X	2.14e-05	6.49e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APOE—metabolic syndrome X	2.14e-05	6.49e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOB—metabolic syndrome X	2.14e-05	6.49e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	2.14e-05	6.47e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.12e-05	6.44e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—metabolic syndrome X	2.12e-05	6.43e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	2.12e-05	6.42e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APOA1—metabolic syndrome X	2.12e-05	6.42e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—metabolic syndrome X	2.1e-05	6.35e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PPARG—metabolic syndrome X	2.08e-05	6.31e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PLA2G4A—metabolic syndrome X	2.08e-05	6.31e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GOT2—metabolic syndrome X	2.08e-05	6.3e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	2.08e-05	6.3e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GOT2—metabolic syndrome X	2.06e-05	6.24e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	2.06e-05	6.24e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—G6PD—metabolic syndrome X	2.05e-05	6.23e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—metabolic syndrome X	2.05e-05	6.21e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—AKT1—metabolic syndrome X	2.05e-05	6.21e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—LPL—metabolic syndrome X	2.04e-05	6.19e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—INS—metabolic syndrome X	2.04e-05	6.19e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.04e-05	6.18e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOB—metabolic syndrome X	2.02e-05	6.13e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	2.01e-05	6.1e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	2.01e-05	6.1e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	2.01e-05	6.08e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFB1—metabolic syndrome X	1.98e-05	5.99e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PLA2G4A—metabolic syndrome X	1.97e-05	5.96e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ABCA1—metabolic syndrome X	1.97e-05	5.96e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	1.97e-05	5.96e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.96e-05	5.94e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.96e-05	5.94e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—AKT1—metabolic syndrome X	1.96e-05	5.93e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GOT1—metabolic syndrome X	1.95e-05	5.91e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GGT1—metabolic syndrome X	1.95e-05	5.91e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CD36—metabolic syndrome X	1.94e-05	5.88e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—LPL—metabolic syndrome X	1.93e-05	5.85e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IRS1—metabolic syndrome X	1.91e-05	5.79e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFB1—metabolic syndrome X	1.91e-05	5.77e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GGT1—metabolic syndrome X	1.9e-05	5.77e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GOT1—metabolic syndrome X	1.9e-05	5.77e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.9e-05	5.75e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—AKT1—metabolic syndrome X	1.89e-05	5.73e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—metabolic syndrome X	1.88e-05	5.71e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—AKT1—metabolic syndrome X	1.88e-05	5.7e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.88e-05	5.69e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALB—metabolic syndrome X	1.87e-05	5.67e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.86e-05	5.63e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.85e-05	5.61e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.85e-05	5.61e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—metabolic syndrome X	1.85e-05	5.6e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOB—metabolic syndrome X	1.84e-05	5.59e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	1.84e-05	5.56e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	1.84e-05	5.56e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CD36—metabolic syndrome X	1.83e-05	5.56e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—INS—metabolic syndrome X	1.83e-05	5.54e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARA—metabolic syndrome X	1.81e-05	5.47e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TGFB1—metabolic syndrome X	1.8e-05	5.46e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL2—metabolic syndrome X	1.8e-05	5.45e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.79e-05	5.44e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.79e-05	5.44e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PLA2G4A—metabolic syndrome X	1.79e-05	5.43e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—NOS3—metabolic syndrome X	1.79e-05	5.43e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GGT1—metabolic syndrome X	1.78e-05	5.39e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GOT1—metabolic syndrome X	1.78e-05	5.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IGF1—metabolic syndrome X	1.77e-05	5.36e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—LPL—metabolic syndrome X	1.76e-05	5.33e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—AGT—metabolic syndrome X	1.75e-05	5.3e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.75e-05	5.29e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—AKT1—metabolic syndrome X	1.74e-05	5.27e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOE—metabolic syndrome X	1.71e-05	5.19e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—AKT1—metabolic syndrome X	1.71e-05	5.17e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARA—metabolic syndrome X	1.71e-05	5.17e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOA1—metabolic syndrome X	1.69e-05	5.13e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SERPINE1—metabolic syndrome X	1.68e-05	5.09e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CD36—metabolic syndrome X	1.67e-05	5.07e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOB—metabolic syndrome X	1.65e-05	5.01e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—AGT—metabolic syndrome X	1.65e-05	5.01e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—metabolic syndrome X	1.64e-05	4.96e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOE—metabolic syndrome X	1.62e-05	4.9e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOB—metabolic syndrome X	1.62e-05	4.89e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	1.61e-05	4.88e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NOS3—metabolic syndrome X	1.6e-05	4.86e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOA1—metabolic syndrome X	1.6e-05	4.85e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—metabolic syndrome X	1.59e-05	4.81e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—LPL—metabolic syndrome X	1.58e-05	4.79e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.57e-05	4.76e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.57e-05	4.75e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.56e-05	4.72e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.56e-05	4.72e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARA—metabolic syndrome X	1.55e-05	4.71e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.55e-05	4.69e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—LPL—metabolic syndrome X	1.54e-05	4.67e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.52e-05	4.61e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—metabolic syndrome X	1.52e-05	4.59e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOB—metabolic syndrome X	1.51e-05	4.57e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AGT—metabolic syndrome X	1.51e-05	4.56e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.5e-05	4.55e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CD36—metabolic syndrome X	1.5e-05	4.55e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARG—metabolic syndrome X	1.49e-05	4.52e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—metabolic syndrome X	1.49e-05	4.51e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.48e-05	4.49e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOE—metabolic syndrome X	1.48e-05	4.47e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	1.47e-05	4.45e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CD36—metabolic syndrome X	1.47e-05	4.44e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—INS—metabolic syndrome X	1.46e-05	4.43e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOA1—metabolic syndrome X	1.46e-05	4.42e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.45e-05	4.4e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—LPL—metabolic syndrome X	1.44e-05	4.37e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.44e-05	4.36e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—metabolic syndrome X	1.44e-05	4.35e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARG—metabolic syndrome X	1.41e-05	4.27e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.4e-05	4.23e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARA—metabolic syndrome X	1.4e-05	4.23e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—INS—metabolic syndrome X	1.38e-05	4.19e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.38e-05	4.18e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AKT1—metabolic syndrome X	1.37e-05	4.16e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CD36—metabolic syndrome X	1.37e-05	4.15e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.36e-05	4.13e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.36e-05	4.12e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.36e-05	4.12e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—metabolic syndrome X	1.35e-05	4.1e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AGT—metabolic syndrome X	1.35e-05	4.1e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—metabolic syndrome X	1.34e-05	4.07e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AKT1—metabolic syndrome X	1.32e-05	4.01e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOE—metabolic syndrome X	1.32e-05	4.01e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AGT—metabolic syndrome X	1.32e-05	4e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOA1—metabolic syndrome X	1.31e-05	3.97e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOE—metabolic syndrome X	1.29e-05	3.92e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARG—metabolic syndrome X	1.29e-05	3.89e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARA—metabolic syndrome X	1.28e-05	3.89e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NOS3—metabolic syndrome X	1.28e-05	3.89e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.28e-05	3.87e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARA—metabolic syndrome X	1.27e-05	3.86e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—metabolic syndrome X	1.27e-05	3.84e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—INS—metabolic syndrome X	1.26e-05	3.82e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—AKT1—metabolic syndrome X	1.25e-05	3.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AKT1—metabolic syndrome X	1.25e-05	3.78e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AGT—metabolic syndrome X	1.24e-05	3.77e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—metabolic syndrome X	1.24e-05	3.75e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AGT—metabolic syndrome X	1.23e-05	3.73e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOE—metabolic syndrome X	1.22e-05	3.69e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NOS3—metabolic syndrome X	1.21e-05	3.67e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.21e-05	3.67e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.21e-05	3.67e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOE—metabolic syndrome X	1.21e-05	3.66e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOA1—metabolic syndrome X	1.2e-05	3.65e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—metabolic syndrome X	1.2e-05	3.62e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOA1—metabolic syndrome X	1.19e-05	3.62e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	1.17e-05	3.56e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.17e-05	3.55e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.17e-05	3.55e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARG—metabolic syndrome X	1.15e-05	3.5e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—metabolic syndrome X	1.14e-05	3.46e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—AKT1—metabolic syndrome X	1.14e-05	3.46e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—INS—metabolic syndrome X	1.13e-05	3.43e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARG—metabolic syndrome X	1.13e-05	3.41e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—metabolic syndrome X	1.11e-05	3.36e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NOS3—metabolic syndrome X	1.11e-05	3.35e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—INS—metabolic syndrome X	1.1e-05	3.35e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AKT1—metabolic syndrome X	1.1e-05	3.34e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARG—metabolic syndrome X	1.06e-05	3.22e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—metabolic syndrome X	1.06e-05	3.21e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—AKT1—metabolic syndrome X	1.05e-05	3.19e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARG—metabolic syndrome X	1.05e-05	3.19e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—INS—metabolic syndrome X	1.04e-05	3.15e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—metabolic syndrome X	1.04e-05	3.14e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—INS—metabolic syndrome X	1.03e-05	3.13e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—metabolic syndrome X	1.01e-05	3.07e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—metabolic syndrome X	1.01e-05	3.06e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOB—metabolic syndrome X	9.95e-06	3.02e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NOS3—metabolic syndrome X	9.92e-06	3.01e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NOS3—metabolic syndrome X	9.69e-06	2.93e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	9.68e-06	2.93e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—metabolic syndrome X	9.54e-06	2.89e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LPL—metabolic syndrome X	9.5e-06	2.88e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—metabolic syndrome X	9.46e-06	2.87e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NOS3—metabolic syndrome X	9.13e-06	2.77e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	9.08e-06	2.75e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NOS3—metabolic syndrome X	9.05e-06	2.74e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CD36—metabolic syndrome X	9.03e-06	2.74e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—metabolic syndrome X	8.86e-06	2.68e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARA—metabolic syndrome X	8.39e-06	2.54e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	8.35e-06	2.53e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	8.28e-06	2.51e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—AKT1—metabolic syndrome X	8.23e-06	2.5e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AGT—metabolic syndrome X	8.13e-06	2.46e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—metabolic syndrome X	7.99e-06	2.42e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOE—metabolic syndrome X	7.96e-06	2.41e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOA1—metabolic syndrome X	7.87e-06	2.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AKT1—metabolic syndrome X	7.38e-06	2.23e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARG—metabolic syndrome X	6.94e-06	2.1e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—INS—metabolic syndrome X	6.8e-06	2.06e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—metabolic syndrome X	6.24e-06	1.89e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NOS3—metabolic syndrome X	5.97e-06	1.81e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—AKT1—metabolic syndrome X	5.9e-06	1.79e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—AKT1—metabolic syndrome X	5.57e-06	1.69e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	5.46e-06	1.65e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AKT1—metabolic syndrome X	5.08e-06	1.54e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AKT1—metabolic syndrome X	4.56e-06	1.38e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AKT1—metabolic syndrome X	4.45e-06	1.35e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AKT1—metabolic syndrome X	4.2e-06	1.27e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AKT1—metabolic syndrome X	4.16e-06	1.26e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.74e-06	8.31e-06	CbGpPWpGaD
